Direct health costs and clinical outcomes of open surgery in patients with abdominal aortic aneurysm in Spain. The RECAPTA study [0.03%]
西班牙腹主动脉瘤患者的开放手术直接医疗费用及临床结局──RECAPTA研究
Marta Egea,Rafael Fernández-Samos,José Antonio Lechón et al.
Marta Egea et al.
Objective: Abdominal aortic aneurysm (AAA) is a chronic, progressive disease that often requires surgical repair. This study aimed to assess the healthcare costs and clinical outcomes of open AAA repair in Spain. ...
Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC) [0.03%]
非小细胞肺癌(NSCLC)治疗的经济学分析评论
Alain Vergnenègre,Christos Chouaïd
Alain Vergnenègre
Introduction: During the past few years, medical-economic evaluation of lung cancers (LCs) has become unavoidable. Total management costs have been rising constantly, with values almost doubling every 10 years. The financ...
Immunosuppressants in Brazil: underlying drivers of spending trends, 2010-2015 [0.03%]
2010年至2015年巴西免疫抑制剂支出趋势及其影响因素分析
Jéssica de Castro Alves,Claudia Garcia Serpa Osorio-de-Castro,Bjorn Wettermark et al.
Jéssica de Castro Alves et al.
Background: Immunosuppressants are recommended for treatment of autoimmune diseases, and in transplant therapy. The high cost of these drugs has been causing an important impact on global pharmaceutical spending. ...
Systematic review of healthcare costs related to mental health conditions among cancer survivors [0.03%]
癌症幸存者相关精神健康状况的卫生保健成本系统评价研究
Jaya S Khushalani,Jin Qin,John Cyrus et al.
Jaya S Khushalani et al.
Introduction: This systematic review examines healthcare costs associated with mental health conditions among cancer survivors in the United States. Areas...
Analysis of the drug formulary and the purchasing process at a Moroccan university medical center [0.03%]
摩洛哥大学医学中心的药物目录和采购过程分析
Z Lachhab,S Serragui,M Hassar et al.
Z Lachhab et al.
Aim: To give an overview of the pharmaceutical policy in the largest medical center in Morocco, a developing country in socio-economic transition. Methods...
Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries [0.03%]
评估海湾合作委员会国家卫生经济学和药物经济学文献的数量和质量
Islam Eljilany,Faris El-Dahiyat,Louise Elizabeth Curley et al.
Islam Eljilany et al.
Background: The importance of pharmacoeconomics and health economics has been augmented. It has the potential to provide evidence to aid in optimal decision-making in the funding of cost-effective medicines and services i...
The cost of preterm labor and preterm birth for mothers with uncomplicated pregnancies and their infants in Italy: a retrospective cohort study [0.03%]
意大利未发生并发症的母亲及其早产儿的早产和极低出生体重婴儿的成本：一项回顾性队列研究
Evie Merinopoulou,Shibani Pokras,Jeanne M Pimenta et al.
Evie Merinopoulou et al.
Background: Preterm labor (PTL)/preterm birth (PTB) impose significant burden on health-care systems. Women with uncomplicated pregnancies at risk of PTL/PTB have not been widely investigated, and published evidence on th...
Cost-savings for biosimilars in the United States: a theoretical framework and budget impact case study application using filgrastim [0.03%]
美国生物类似药的成本节约：理论框架及预算影响案例研究应用——以非格司亭为例
Simrun Grewal,Scott Ramsey,Sanjeev Balu et al.
Simrun Grewal et al.
Background: Biosimilars can directly reduce the cost of treating patients for whom a reference biologic is indicated by offering a highly similar, lower priced alternative. We examine factors related to biosimilar regulat...
Clinical outcome and prognostic analysis of meningeal carcinomatosis treated by intrathecal chemotherapy [0.03%]
腰穿化疗治疗脑膜转移的临床疗效及预后分析
Zhaohua Meng,Qinqin Zhang,Kun Hong et al.
Zhaohua Meng et al.
Objective: To evaluate the clinical efficacy of meningeal carcinomatosis (MC) treated by intrathecal chemotherapy (IC) and analyzes the prognostic factors. ...
Economic evaluation of prescribing conventional and newer oral anticoagulants in older adults [0.03%]
老年患者使用传统和新型口服抗凝药的经济学评价
Syed Shahzad Hasan,Chia Siang Kow,Louise E Curley et al.
Syed Shahzad Hasan et al.
Introduction: Anticoagulants refer to a variety of agents that inhibit one or more steps in the coagulation cascade. Generally, clinical conditions that require the prescribing of an oral anticoagulant increase in frequen...